Brief Communication: Sirolimus-Associated Pneumonitis: 24 Cases in Renal Transplant Recipients

  1. Laure Champion, MD;
  2. Marc Stern, MD;
  3. Dominique Israël-Biet, MD, PhD;
  4. Marie-France Mamzer-Bruneel, MD;
  5. Marie-Noëlle Peraldi, MD;
  6. Henri Kreis, MD;
  7. Raphaël Porcher, MD; and
  8. Emmanuel Morelon, MD, PhD
  1. From Hôpital Saint Louis, Hôpital Necker, Hôpital Foch, Hôpital Georges Pompidou, and Hôpital Edouard Herriot, Paris, France.

    Abstract

    Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppressant drug recently introduced for patients having organ transplantation.

    Objective: To evaluate clinical and laboratory features of sirolimus-associated pneumonitis.

    Design: Case series.

    Setting: 1 transplantation center in Paris, France.

    Patients: 24 patients who had renal transplantation and developed sirolimus-associated pneumonitis, including 8 patients previously reported.

    Measurements: Symptoms; laboratory tests, including bronchoalveolar fluid analysis; and computed tomography (CT) of the chest.

    Intervention: Withdrawal or dose reduction of sirolimus.

    Results: Clinical symptoms included cough (23 patients), fatigue (20 patients), fever (16 patients), and dyspnea (8 patients). Computed tomography of the chest showed reticular and ground-glass opacities (4 patients), bronchiolitis obliterans–organizing pneumonia (19 patients), and lobar consolidation (1 patient). Bronchoalveolar lavage showed lymphocytic (19 patients) or eosinophilic (3 patients) alveolitis or pulmonary hemorrhage (2 patients). A reduction in the sirolimus dose resulted in transient clinical improvement in 2 patients, but discontinuation of drug therapy was eventually necessary in all patients. All patients recovered completely within 6 months.

    Limitations: The sirolimus trough level in patients from this single center was higher than that usually used in patients having renal transplantation.

    Conclusion: Lymphocytic alveolitis and radiologic bronchiolitis obliterans–organizing pneumonia are the key findings in sirolimus-associated pneumonitis. Sirolimus withdrawal was associated with recovery within 6 months.

    Article and Author Information

    • Grant Support: None.

    • Potential Financial Conflicts of Interest: None disclosed.

    • Requests for Single Reprints: Emmanuel Morelon, MD, PhD, Service de Néphrologie, Médecine de Transplantation et Immunologie Clinique, Université Claude Bernard Lyon 1, Hôpital Edouard Herriot, 3 place d'Arsonval, 69437 Lyon, Cedex 03, France; e-mail, emmanuel.morelon{at}chu-lyon.fr.

    • Current Author Addresses: Drs. Champion and Peraldi: Service de Néphrologie et de Transplantation, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France.

    • Dr. Stern: Service de Pneumologie, Hôpital Foch, 40 rue Worth, 92150 Suresnes, France.

    • Dr. Israël-Biet: Service de Pneumologie, Hôpital Georges Pompidou, 20 rue Leblanc, 75015 Paris, Cedex 15, France.

    • Drs. Mamzer-Bruneel and Kreis: Service de Transplantation et de Réanimation, Hôpital Necker, 149 rue de Sevres, 75743 Paris, Cedex 15, France.

    • Dr. Porcher: Département de Biostatistique et Informatique Médicale, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75475 Paris, Cedex 10, France.

    • Dr. Morelon: Service de Néphrologie, Médecine de Transplantation et Immunologie Clinique, Université Claude Bernard Lyon 1, Hôpital Edouard Herriot, 3 place d'Arsonval, 69437 Lyon, Cedex 03, France.

    • Author Contributions: Conception and design: L. Champion, M. Stern, E. Morelon.

    • Analysis and interpretation of the data: L. Champion, M. Stern, D. Israël-Biet, E. Morelon.

    • Drafting of the article: L. Champion, M. Stern, D. Israël-Biet, E. Morelon.

    • Critical revision of the article for important intellectual content: L. Champion, M. Stern, D. Israël-Biet, E. Morelon.

    • Final approval of the article: L. Champion, M. Stern, D. Israël-Biet, M.-F. Mamzer-Bruneel, M.-N. Peraldi, H. Kreis, E. Morelon.

    • Provision of study materials or patients: M.-F. Mamzer-Bruneel, M.-N. Peraldi, H. Kreis.

    • Statistical expertise: R. Porcher.

    • Administrative, technical, or logistic support: D. Israël-Biet, H. Kreis.

    Comments on This Article

    Summary for Patients

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement